Stay updated on MK-3222-010 Clinical Trial: Psoriasis Efficacy & Safety
Sign up to get notified when there's something new on the MK-3222-010 Clinical Trial: Psoriasis Efficacy & Safety page.

Latest updates to the MK-3222-010 Clinical Trial: Psoriasis Efficacy & Safety page
- Check6 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check13 days agoChange DetectedNo user-impacting content changes detected; the study details and sections appear unchanged.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedA new site revision tag 'Revision: v3.4.2' is now displayed at the top of the page. The notice about government funding and the previous 'Revision: v3.4.1' text were removed.SummaryDifference0.4%

- Check41 days agoChange DetectedA site-wide notice about a lapse in government funding was added and the page version updated to v3.4.1 (replacing v3.4.0); no core study content changed, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check48 days agoChange DetectedAdded a glossary display option and updated metadata labels, including 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', with Revision set to v3.4.0. The previous labels ('Last Update Submitted that met QC Criteria' and 'No FEAR Act data') and v3.3.4 were removed.SummaryDifference0.2%

- Check62 days agoChange DetectedThe page revision updated from v3.3.3 to v3.3.4, which appears to be an internal versioning update with no changes to the study content displayed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to MK-3222-010 Clinical Trial: Psoriasis Efficacy & Safety
Enter your email address, and we'll notify you when there's something new on the MK-3222-010 Clinical Trial: Psoriasis Efficacy & Safety page.